Abstract
An HIV-1-seropositive volunteer was infused with an expanded autologous cytotoxic T lymphocyte (CTL) clone directed against the HIV-1 net protein. This clone was adoptively transferred to determine whether supplementing CTL activity could reduce viral load or improve clinical course. Unexpectedly, infusion was followed by a decline in circulating CD4+T cells and a rise in viral load. Some of the HIV isolates obtained from the plasma or CD4+cells of the patient were lacking the nef epitope. These results suggest that active CTL selection of viral variants could contribute to the pathogenesis of AIDS and that clinical progression can occur despite high levels of circulating HIV-1-specific CTLs.
Original language | English |
---|---|
Pages (from-to) | 330-336 |
Number of pages | 7 |
Journal | Nature Medicine |
Volume | 1 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1995 |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology